Ventas Inc. (VTR), a real estate investment trust focused on healthcare properties, saw its stock soar 7.96% in Thursday's intraday trading session, following the company's impressive fourth-quarter 2024 results and positive outlook for 2025.
The healthcare REIT reported normalized funds from operations (FFO) per share of $0.81 for Q4 2024, beating analysts' estimates by a penny and marking a 6.6% year-over-year increase. Revenues of $1.29 billion also surpassed expectations and grew 10.5% compared to the same period last year.
A significant driver of Ventas' strong performance was the robust growth in same-store cash net operating income (NOI), which climbed 8.4% for the company's total portfolio. Notably, the Senior Housing Operating Portfolio (SHOP) segment saw a remarkable 16.9% increase in same-store cash NOI, fueled by higher average occupancy rates and revenue per occupied room.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。